Table 4

Characteristics of CPC+ Participants and Nonparticipants Among CPC+ Applicants, Based on Medicare FFS Beneficiary Composition, Before CPC+

CharacteristicApplicants (n = 4,346)aAmong Applicants P Value
Participants (n = 3,051)b,cNonparticipants (n = 1,295)
Characteristics of Medicare FFS beneficiaries attributed to practice at baselined
Age
 0-49 y, % (95% CI)6.0 (5.8-6.2)5.2 (5.1-5.4)7.9 (7.5-8.4)< .001
 50-64 y, % (95% CI)13.1 (12.9-13.4)12.0 (11.7-12.2)15.9 (15.4-16.4)< .001
 65-74 y, % (95% CI)45.3 (45.0-45.6)46.1 (45.8-46.4)43.3 (42.7-44.0)< .001
 75-84 y, % (95% CI)24.1 (23.9-24.3)24.9 (24.7-25.1)22.2 (21.7-22.6)< .001
 ≥ 85 y, % (95% CI)11.5 (11.3-11.7)11.8 (11.6-12.0)10.7 (10.2-11.1)< .001
Male, % (95% CI)41.6 (41.4-41.9)41.7 (41.4-41.9)41.5 (41.0-42.1).664
Race
 Black, % (95% CI)8.5 (8.1-9.0)6.9 (6.5-7.4)12.3 (11.3-13.4)< .001
 White, % (95% CI)84.3 (83.7-84.9)85.8 (85.1-86.5)80.8 (79.6-82.0)< .001
 Other, % (95% CI)7.2 (6.8-7.6)7.3 (6.8-7.8)6.9 (6.2-7.6).383
Dually eligible for Medicare and Medicaid, % (95% CI)e17.0 (16.6-17.5)14.9 (14.4-15.4)22.0 (21.0-23.0)< .001
HCC score attributed in baseline year, mean (95% CI)f1.12 (1.11-1.13)1.10 (1.10-1.11)1.16 (1.14-1.18)< .001
Chronic conditions as of baseline yearg
 Alzheimer disease and related dementia, % (95% CI)7.7 (7.5-7.9)7.4 (7.2-7.5)8.4 (8.0-8.9)< .001
 Cancer, % (95% CI)7.6 (7.5-7.7)7.9 (7.8-8.0)7.0 (6.8-7.1)< .001
 Chronic obstructive pulmonary disease, % (95% CI)10.8 (10.7-11.0)10.3 (10.2-10.5)12.0 (11.6-12.4)< .001
 Chronic kidney disease, % (95% CI)16.8 (16.6-17.1)16.4 (16.2-16.6)17.9 (17.4-18.4)< .001
 Congestive heart failure, % (95% CI)11.4 (11.2-11.6)11.0 (10.8-11.1)12.4 (11.9-12.8)< .001
 Diabetes, % (95% CI)26.3 (26.1-26.6)25.7 (25.4-26.0)27.8 (27.2-28.4)< .001
Medicare FFS expenditures and service use for Medicare FFS beneficiaries attributed to practice at baseline
Medicare expenditures per beneficiary ($/mo), median (IQR)h,i858 (744-1,004)850 (745-981)874 (737-1,090)< .001
Weighted Medicare expenditures per beneficiary ($/mo), median (IQR)h,i855 (761-976)849 (757-964)869 (768-1,020)< .001
Acute care stays per 1,000 beneficiaries (annualized), median (IQR)282 (233-346)276 (231-331)302 (239-390)< .001
ED visits per 1,000 beneficiaries (annualized), median (IQR)481 (374-638)465 (366-598)537 (397-753)< .001
Primary care (ambulatory) visits per 1,000 beneficiaries (annualized), median (IQR)4,471 (3,927-5,161)4,443 (3,917-5,087)4,565 (3,957-5,503)< .001
Percentage of discharges for which beneficiary had a 14-day follow-up visit after hospitalization, median (IQR)j69.1 (63.0-74.4)69.6 (64.0-74.5)67.8 (60.4-74.3)< .001
  • CMS = Centers for Medicare and Medicaid Services; CPC+ = Comprehensive Primary Care Plus; ED = emergency department; FFS = fee for service; HCC = hierarchical condition category; IQR = interquartile range.

  • Note: Primary care practices include all practices with ≥ 1 practitioner (defined as a physician, nurse practitioner, or physician assistant) with a specialty of primary care (defined as family practice, general practice, geriatrics, or internal medicine). The 2018 starters represent 11% of all practices, 7% of applicants, and 5% of participants.

  • Sources: Mathematica’s analysis of data on the number, characteristics, and service use and spending of attributed Medicare beneficiaries based on Medicare Enrollment Database and claims data.

  • a A total of 4,599 practices applied for CPC+. The number of applicants in this table (4,346) is fewer because some applicants could not be identified in the SK&A data, and some applicants had no attributed Medicare FFS beneficiaries at baseline.

  • b The 2018 starters comprise approximately 5% of the participating CPC+ practices and 5% of attributed beneficiaries.

  • c As of April 1 of the first intervention year.

  • d The baseline year is 2016 for the 2017 starters and 2017 for the 2018 starters.

  • e Calculated as the percentage of beneficiaries attributed to a practice in the baseline year who were dually eligible for Medicare and Medicaid in the quarter before the start of the baseline year.

  • f The HCC score is based on beneficiaries’ diagnoses in 2015 (for 2017 starters) or 2016 (for 2018 starters).

  • g The lookback periods for the chronic conditions are 3 years before the baseline year for Alzheimer and related dementia, 1 year before the baseline year for cancer and chronic obstructive pulmonary disease, and 2 years before the baseline year for chronic kidney disease, congestive heart failure, and diabetes.

  • h We deflated the 2017 (baseline) mean and median per beneficiary per month expenditures for the practices in the 2018 CPC+ regions by the 0.9% Medicare inflation rate (CMS Office of the Actuary, personal communication, May 6, 2019).

  • i For the calculation of the weighted (mean/median) monthly Medicare expenditures per beneficiary, the practice-level expenditure variable (mean/median) is weighted by the number of beneficiaries attributed to the practice, so that practices with more attributed beneficiaries get a greater weight. The means and medians for all of the other characteristics in the table are unweighted, meaning that each practice is treated equally, regardless of its size.

  • j This measure was calculated for beneficiaries attributed in the first quarter of the baseline year.